{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["NF-\u03baB", "anticancer effect", "apoptosis", "grifolin", "pharmacodynamic"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35011516", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "10"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "03"}], "Language": ["eng"], "ELocationID": ["284", "10.3390/molecules27010284"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "03"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Pharmacological Effects of Grifolin: Focusing on Anticancer Mechanisms.", "Abstract": {"AbstractText": ["Grifolin is a volatile compound contained in essential oils of several medicinal plants. Several studies show that this substance has been the subject of numerous pharmacological investigations, which have yielded interesting results. Grifolin demonstrated beneficial effects for health via its multiple pharmacological activities. It has anti-microbial properties against bacteria, fungi, and parasites. In addition, grifolin exhibited remarkable anti-cancer effects on different human cancer cells. The anticancer action of this molecule is related to its ability to act at cellular and molecular levels on different checkpoints controlling the signaling pathways of human cancer cell lines. Grifolin can induce apoptosis, cell cycle arrest, autophagy, and senescence in these cells. Despite its major pharmacological properties, grifolin has only been investigated in vitro and in vivo. Therefore, further investigations concerning pharmacodynamic and pharmacokinetic tests are required for any possible pharmaceutical application of this substance. Moreover, toxicological tests and other investigations involving humans as a study model are required to validate the safety and clinical applications of grifolin."]}, "AuthorList": [{"Identifier": ["0000-0001-9317-1631"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, Mohammed V University, Rabat 10106, Morocco."}], "LastName": "Bouyahya", "ForeName": "Abdelhakim", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, Mohammed V University, Rabat 10106, Morocco."}], "LastName": "El Allam", "ForeName": "Aicha", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Industry Laboratory, National Agency of Medicinal and Aromatic Plants, Taounate 34025, Morocco."}], "LastName": "Zeouk", "ForeName": "Ikrame", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire de Spectroscopie, Mod\u00e9lisation Mol\u00e9culaire, Mat\u00e9riaux, Nanomat\u00e9riaux, Eau et Environnement, CERNE2D, Facult\u00e9 des Sciences, Mohammed V University, Rabat 10106, Morocco."}], "LastName": "Taha", "ForeName": "Douae", "Initials": "D"}, {"Identifier": ["0000-0001-6548-7823"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Physiology and Biochemistry Research Laboratory, Department of Biology, Science Faculty, Selcuk University, 42130 Konya, Turkey."}], "LastName": "Zengin", "ForeName": "Gokhan", "Initials": "G"}, {"Identifier": ["0000-0003-1006-3649"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biofunctional Molecule Exploratory (BMEX) Research Group, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang Jaya 47500, Malaysia."}, {"Identifier": [], "Affiliation": "College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China."}], "LastName": "Goh", "ForeName": "Bey Hing", "Initials": "BH"}, {"Identifier": ["0000-0002-4448-6984"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Engineering, University of Campania \"Luigi Vanvitelli\", Via Roma 29, 81031 Aversa, Italy."}], "LastName": "Catauro", "ForeName": "Michelina", "Initials": "M"}, {"Identifier": ["0000-0002-8857-2091"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Naples Federico II, via D. Montesano 49, 80131 Naples, Italy."}], "LastName": "Montesano", "ForeName": "Domenico", "Initials": "D"}, {"Identifier": ["0000-0002-0308-1155"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Histology, Embryology and Cytogenetic, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat 10100, Morocco."}], "LastName": "El Omari", "ForeName": "Nasreddine", "Initials": "N"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Terpenes"}, {"RegistryNumber": "6379-55-1", "NameOfSubstance": "grifolin"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacokinetics", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Autophagy"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["chemistry", "pharmacokinetics", "therapeutic use"], "DescriptorName": "Terpenes"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Armijos C., Ram\u00edrez J., Salinas M., Vidari G., Su\u00e1rez A.I. Pharmacology and phytochemistry of ecuadorian medicinal plants: An update and perspectives. Pharmaceuticals. 2021;14:1145. doi: 10.3390/ph14111145.", "ArticleIdList": ["10.3390/ph14111145", "PMC8624270", "34832927"]}, {"Citation": "Rudrapal M., Khan J., Dukhyil A.A.B., Alarousy R.M.I.I., Attah E.I., Sharma T., Khairnar S.J., Bendale A.R. Chalcone scaffolds, bioprecursors of flavonoids: Chemistry, bioactivities, and pharmacokinetics. Molecules. 2021;26:7177. doi: 10.3390/molecules26237177.", "ArticleIdList": ["10.3390/molecules26237177", "PMC8659147", "34885754"]}, {"Citation": "Balahbib A., El Omari N., Hachlafi N.E., Lakhdar F., El Menyiy N., Salhi N., Mrabti H.N., Bakrim S., Zengin G., Bouyahya A. Health beneficial and pharmacological properties of p-cymene. Food Chem. Toxicol. 2021;11:112259. doi: 10.1016/j.fct.2021.112259.", "ArticleIdList": ["10.1016/j.fct.2021.112259", "33984423"]}, {"Citation": "Bouyahya A., Guaouguaou F.-E., El Omari N., El Menyiy N., Balahbib A., El-Shazly M., Bakri Y. Anti-inflammatory and analgesic properties of moroccan medicinal plants: Phytochemistry, in vitro and in vivo investigations, mechanism insights, clinical evidences and perspectives. J. Pharm. Anal. 2021. In press.", "ArticleIdList": ["10.1016/j.jpha.2021.07.004", "PMC9073245", "35573886"]}, {"Citation": "Bouyahya A., Mechchate H., Benali T., Ghchime R., Charfi S., Balahbib A., Burkov P., Shariati M.A., Lorenzo J.M., Omari N.E. Health benefits and pharmacological properties of carvone. Biomolecules. 2021;11:1803. doi: 10.3390/biom11121803.", "ArticleIdList": ["10.3390/biom11121803", "PMC8698960", "34944447"]}, {"Citation": "Bouyahya A., El Omari N., Elmenyiy N., Guaouguaou F.-E., Balahbib A., Belmehdi O., Salhi N., Imtara H., Mrabti H.N., El-Shazly M. Moroccan antidiabetic medicinal plants: Ethnobotanical studies, phytochemical bioactive compounds, preclinical investigations, toxicological validations and clinical evidences; challenges, guidance and perspectives for future management of diabetes worldwide. Trends Food Sci. Technol. 2021;115:147\u2013254."}, {"Citation": "Langfield R.D., Scarano F.J., Heitzman M.E., Kondo M., Hammond G.B., Neto C.C. Use of a modified microplate bioassay method to investigate antibacterial activity in the peruvian medicinal plant Peperomia Galioides. J. Ethnopharmacol. 2004;94:279\u2013281. doi: 10.1016/j.jep.2004.06.013.", "ArticleIdList": ["10.1016/j.jep.2004.06.013", "15325731"]}, {"Citation": "Wilches I., Jim\u00e9nez-Castillo P., Cuzco N., Clos M.V., Jim\u00e9nez-Altay\u00f3 F., Pe\u00f1aherrera E., Jerves-Andrade L., Tobar V., Vander Heyden Y., Leon-Tamariz F. Anti-inflammatory and sedative activities of Peperomia Galioides: In vivo studies in mice. Nat. Prod. Res. 2021;35:1657\u20131661. doi: 10.1080/14786419.2019.1622104.", "ArticleIdList": ["10.1080/14786419.2019.1622104", "31140298"]}, {"Citation": "Ye C., Jin M., Li R., Sun J., Wang R., Wang J., Li S., Zhou W., Li G. Phytochemical and chemotaxonomic study on the leaves of Rhododendron Dauricum, L. Biochem. Syst. Ecol. 2020;90:104038. doi: 10.1016/j.bse.2020.104038.", "ArticleIdList": ["10.1016/j.bse.2020.104038"]}, {"Citation": "Abdelaali B., El Menyiy N., El Omari N., Benali T., Guaouguaou F.-E., Salhi N., Naceiri Mrabti H., Bouyahya A. Phytochemistry, toxicology, and pharmacological properties of Origanum Elongatum. Evid. Based Complement. Alternat. Med. 2021;2021:6658593. doi: 10.1155/2021/6658593.", "ArticleIdList": ["10.1155/2021/6658593", "PMC8225437", "34221086"]}, {"Citation": "Bouyahya A., Chamkhi I., Benali T., Guaouguaou F.-E., Balahbib A., El Omari N., Taha D., Belmehdi O., Ghokhan Z., El Menyiy N. Traditional use, phytochemistry, toxicology, and pharmacology of Origanum Majorana L. J. Ethnopharmacol. 2021;265:113318. doi: 10.1016/j.jep.2020.113318.", "ArticleIdList": ["10.1016/j.jep.2020.113318", "32882360"]}, {"Citation": "Bouyahya A., Chamkhi I., Guaouguaou F.-E., Benali T., Balahbib A., El Omari N., Taha D., El-Shazly M., El Menyiy N. Ethnomedicinal use, phytochemistry, pharmacology, and food benefits of Thymus Capitatus. J. Ethnopharmacol. 2020;259:112925. doi: 10.1016/j.jep.2020.112925.", "ArticleIdList": ["10.1016/j.jep.2020.112925", "32423878"]}, {"Citation": "Bouyahya A., El Omari N., Elmenyiy N., Guaouguaou F.-E., Balahbib A., El-Shazly M., Chamkhi I. Ethnomedicinal use, phytochemistry, pharmacology, and toxicology of Ajuga Iva (L.) schreb. J. Ethnopharmacol. 2020;258:112875. doi: 10.1016/j.jep.2020.112875.", "ArticleIdList": ["10.1016/j.jep.2020.112875", "32387464"]}, {"Citation": "Luo X., Hong L., Cheng C., Li N., Zhao X., Shi F., Liu J., Fan J., Zhou J., Bode A.M. DNMT1 mediates metabolic reprogramming induced by epstein\u2013barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma. Cell Death Dis. 2018;9:1\u201315. doi: 10.1038/s41419-018-0662-2.", "ArticleIdList": ["10.1038/s41419-018-0662-2", "PMC5966399", "29795311"]}, {"Citation": "Zhao Y., Zhang L., Yan A., Chen D., Xie R., Liu Y., Liang X., Zhao Y., Wei L., Yu J. Grifolic Acid induces GH3 adenoma cell death by inhibiting atp production through a GPR120-independent mechanism. BMC Pharmacol. Toxicol. 2018;19:1\u20139. doi: 10.1186/s40360-018-0215-4.", "ArticleIdList": ["10.1186/s40360-018-0215-4", "PMC5975534", "29843779"]}, {"Citation": "Yaqoob A., Li W.M., Liu V., Wang C., Mackedenski S., Tackaberry L.E., Massicotte H.B., Egger K.N., Reimer K., Lee C.H. Grifolin, neogrifolin and confluentin from the terricolous polypore albatrellus flettii suppress kras expression in human colon cancer cells. PLoS ONE. 2020;15:e0231948. doi: 10.1371/journal.pone.0231948.", "ArticleIdList": ["10.1371/journal.pone.0231948", "PMC7199964", "32369483"]}, {"Citation": "Asakawa Y., Hashimoto T., Ngoc Quang D., Nukada M. Isolation, synthesis and biological activity of grifolic acid derivatives from the inedible mushroom Albatrellus Dispansus. Heterocycles. 2005;65:2431. doi: 10.3987/COM-05-10501.", "ArticleIdList": ["10.3987/COM-05-10501"]}, {"Citation": "Luo D.-Q., Shao H.-J., Zhu H.-J., Liu J.-K. Activity in vitro and in vivo against plant pathogenic fungi of grifolin isolated from the basidiomycete albatrellus dispansus. Z. F\u00fcr Nat. C. 2005;60:50\u201356. doi: 10.1515/znc-2005-1-210.", "ArticleIdList": ["10.1515/znc-2005-1-210", "15787244"]}, {"Citation": "Fournet A., Ferreira M.E., Rojas de Arias A., Fuentes S., Torres S., Inchausti A., Yaluff G., Nakayama H., Mahiou V., Hocquemiller R., et al. In vitro and in vivo leishmanicidal studies of peperomia galioides (piperaceae) Phytomedicine. 1996;3:271\u2013275. doi: 10.1016/S0944-7113(96)80065-1.", "ArticleIdList": ["10.1016/S0944-7113(96)80065-1", "23195082"]}, {"Citation": "Iwata N., Wang N., Yao X., Kitanaka S. Structures and Histamine Release Inhibitory Effects of Prenylated Orcinol Derivatives from Rhododendron Dauricum\u00a01. J. Nat. Prod. 2004;67:1106\u20131109. doi: 10.1021/np0303916.", "ArticleIdList": ["10.1021/np0303916", "15270561"]}, {"Citation": "Taura F., Iijima M., Lee J.-B., Hashimoto T., Asakawa Y., Kurosaki F. Daurichromenic acid-producing oxidocyclase in the young leaves of Rhododendron Dauricum. Nat. Prod. Commun. 2014;9:1934578X1400900928. doi: 10.1177/1934578X1400900928.", "ArticleIdList": ["10.1177/1934578X1400900928", "25918805"]}, {"Citation": "Olennikov D.N., Tankhaeva L.M. Phenolic compounds from Rhododendron Dauricum from the baikal region. Chem. Nat. Compd. 2010;46:471\u2013473. doi: 10.1007/s10600-010-9649-7.", "ArticleIdList": ["10.1007/s10600-010-9649-7"]}, {"Citation": "Hern\u00e1ndez-Ochoa J.S., Levin L.N., Hern\u00e1ndez-Luna C.E., Contreras-Cordero J.F., Ni\u00f1o-Medina G., Ch\u00e1vez-Montes A., L\u00f3pez-Sandin I., Guti\u00e9rrez-Soto G. Antagonistic potential of Macrolepiota sp. against Alternaria Solani as causal agent of early blight disease in tomato plants. Gesunde Pflanz. 2020;72:69\u201376. doi: 10.1007/s10343-019-00484-4.", "ArticleIdList": ["10.1007/s10343-019-00484-4"]}, {"Citation": "Phukan H., Bora C.R., Mitra P.K. Phytochemical screening and GC-MS analysis of methanolic leaf extract of an endemic plant kayea assamica. IOSR J. Pharm. Biol. Sci. 2017;15:7\u201316."}, {"Citation": "Hettwer S., B\u00e4nziger S., Suter B., Obermayer B. Grifolin derivatives from Albatrellus Ovinus as TRPV1 receptor blockers for cosmetic applications. Int. J. Cosmet. Sci. 2017;39:379\u2013385. doi: 10.1111/ics.12385.", "ArticleIdList": ["10.1111/ics.12385", "27883196"]}, {"Citation": "Nukata M., Hashimoto T., Yamamoto I., Iwasaki N., Tanaka M., Asakawa Y. Neogrifolin derivatives possessing anti-oxidative activity from the mushroom Albatrellus Ovinus. Phytochem. 2002;59:731\u2013737. doi: 10.1016/S0031-9422(02)00050-X.", "ArticleIdList": ["10.1016/S0031-9422(02)00050-X", "11909630"]}, {"Citation": "Liu X.-T., Winkler A.L., Schwan W.R., Volk T.J., Rott M.A., Monte A. Antibacterial compounds from mushrooms i: A lanostane-type triterpene and prenylphenol derivatives from jahnoporus hirtus and albatrellus flettii and their activities against Bacillus Cereus and Enterococcus Faecalis. Planta Med. 2010;76:182\u2013185. doi: 10.1055/s-0029-1186001.", "ArticleIdList": ["10.1055/s-0029-1186001", "19644795"]}, {"Citation": "Liu L.-Y., Li Z.-H., Wang G.-Q., Wei K., Dong Z.-J., Feng T., Li G.-T., Li Y., Liu J.-K. Nine New Farnesylphenols from the Basidiomycete Albatrellus Caeruleoporus. Nat. Prod. Bioprospect. 2014;4:119\u2013128. doi: 10.1007/s13659-014-0015-5.", "ArticleIdList": ["10.1007/s13659-014-0015-5", "PMC4004861", "24858140"]}, {"Citation": "Yang X.-L., Qin C., Wang F., Dong Z.-J., Liu J.-K. A new meroterpenoid pigment from the basidiomycete albatrellus confluens. Chem. Biodivers. 2008;5:484\u2013489. doi: 10.1002/cbdv.200890047.", "ArticleIdList": ["10.1002/cbdv.200890047", "18357556"]}, {"Citation": "Ye M., Liu J., Lu Z., Zhao Y., Liu S., Li L., Tan M., Weng X., Li W., Cao Y. Grifolin, a potential antitumor natural product from the mushroom albatrellus confluens, inhibits tumor cell growth by inducing apoptosis in vitro. FEBS Lett. 2005;579:3437\u20133443. doi: 10.1016/j.febslet.2005.05.013.", "ArticleIdList": ["10.1016/j.febslet.2005.05.013", "15949805"]}, {"Citation": "Quang D.N., Hashimoto T., Arakawa Y., Kohchi C., Nishizawa T., Soma G.-I., Asakawa Y. Grifolin derivatives from Albatrellus Caeruleoporus, new inhibitors of nitric oxide production in RAW 264.7 Cells. Bioorg. Med. Chem. 2006;14:164\u2013168. doi: 10.1016/j.bmc.2005.08.005.", "ArticleIdList": ["10.1016/j.bmc.2005.08.005", "16169234"]}, {"Citation": "Jin S., Pang R.-P., Shen J.-N., Huang G., Wang J., Zhou J.-G. Grifolin induces apoptosis via inhibition of PI3K/AKT signalling pathway in human osteosarcoma cells. Apoptosis. 2007;12:1317\u20131326. doi: 10.1007/s10495-007-0062-z.", "ArticleIdList": ["10.1007/s10495-007-0062-z", "17333316"]}, {"Citation": "Song J., Manir M.M., Moon S.-S. Cytotoxic grifolin derivatives isolated from the wild mushroom boletus pseudocalopus (basidiomycetes) Chem. Biodivers. 2009;6:1435\u20131442. doi: 10.1002/cbdv.200800217.", "ArticleIdList": ["10.1002/cbdv.200800217", "19774605"]}, {"Citation": "Ye M., Luo X., Li L., Shi Y., Tan M., Weng X., Li W., Liu J., Cao Y. Grifolin, a potential antitumor natural product from the mushroom albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway. Cancer Lett. 2007;258:199\u2013207. doi: 10.1016/j.canlet.2007.09.001.", "ArticleIdList": ["10.1016/j.canlet.2007.09.001", "18029087"]}, {"Citation": "Luo X., Li L., Deng Q., Yu X., Yang L., Luo F., Xiao L., Chen X., Ye M., Liu J. Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via P53 in nasopharyngeal carcinoma cells. Eur. J. Cancer. 2011;47:316\u2013325. doi: 10.1016/j.ejca.2010.09.021.", "ArticleIdList": ["10.1016/j.ejca.2010.09.021", "20943371"]}, {"Citation": "Luo X., Yang L., Xiao L., Xia X., Dong X., Zhong J., Liu Y., Li N., Chen L., Li H. Grifolin directly targets ERK1/2 to epigenetically suppress cancer cell metastasis. Oncotarget. 2015;6:42704. doi: 10.18632/oncotarget.5678.", "ArticleIdList": ["10.18632/oncotarget.5678", "PMC4767464", "26516701"]}, {"Citation": "Che X., Yan H., Sun H., Dongol S., Wang Y., Lv Q., Jiang J. Grifolin induces autophagic cell death by inhibiting the Akt/MTOR/S6K pathway in human ovarian cancer cells. Oncol. Rep. 2016;36:1041\u20131047. doi: 10.3892/or.2016.4840.", "ArticleIdList": ["10.3892/or.2016.4840", "27277722"]}, {"Citation": "Luo X., Li N., Zhong J., Tan Z., Liu Y., Dong X., Cheng C., Xu Z., Li H., Yang L. Grifolin inhibits tumor cells adhesion and migration via suppressing interplay between PGC1\u03b1 and Fra-1/LSF-MMP2/CD44 axes. Oncotarget. 2016;7:68708. doi: 10.18632/oncotarget.11929.", "ArticleIdList": ["10.18632/oncotarget.11929", "PMC5356584", "27626695"]}, {"Citation": "Yang S., Wang X., Zhong G. Grifolin, a potent antitumor natural product inhibits the growth and invasion of gastric cancer cells in vitro. Int. J. Clin. Exp. Med. 2016;9:12659\u201312668."}, {"Citation": "Wu Z., Li Y. Grifolin exhibits anti-cancer activity by inhibiting the development and invasion of gastric tumor cells. Oncotarget. 2017;8:21454. doi: 10.18632/oncotarget.15250.", "ArticleIdList": ["10.18632/oncotarget.15250", "PMC5400597", "28206955"]}, {"Citation": "Yan H., Che X., Lv Q., Zhang L., Dongol S., Wang Y., Sun H., Jiang J. Grifolin induces apoptosis and promotes cell cycle arrest in the A2780 human ovarian cancer cell line via inactivation of the ERK1/2 and Akt pathways. Oncol. Lett. 2017;13:4806\u20134812. doi: 10.3892/ol.2017.6092.", "ArticleIdList": ["10.3892/ol.2017.6092", "PMC5452918", "28588729"]}, {"Citation": "Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and P38 protein kinases. Science. 2002;298:1911\u20131912. doi: 10.1126/science.1072682.", "ArticleIdList": ["10.1126/science.1072682", "12471242"]}, {"Citation": "Cagnol S., Chambard J.-C. ERK and cell death: Mechanisms of ERK-induced cell death\u2013apoptosis, autophagy and senescence. FEBS J. 2010;277:2\u201321. doi: 10.1111/j.1742-4658.2009.07366.x.", "ArticleIdList": ["10.1111/j.1742-4658.2009.07366.x", "19843174"]}, {"Citation": "Machesky L.M. Lamellipodia and filopodia in metastasis and invasion. FEBS Lett. 2008;582:2102\u20132111. doi: 10.1016/j.febslet.2008.03.039.", "ArticleIdList": ["10.1016/j.febslet.2008.03.039", "18396168"]}, {"Citation": "Zi D., Zhou Z.-W., Yang Y.-J., Huang L., Zhou Z.-L., He S.-M., He Z.-X., Zhou S.-F. Danusertib induces apoptosis, cell cycle arrest, and autophagy but inhibits epithelial to mesenchymal transition involving PI3K/Akt/MTOR signaling pathway in human ovarian cancer cells. Int. J. Mol. Sci. 2015;16:27228\u201327251. doi: 10.3390/ijms161126018.", "ArticleIdList": ["10.3390/ijms161126018", "PMC4661876", "26580601"]}, {"Citation": "Wang K.-F., Yang H., Jiang W.-Q., Li S., Cai Y.-C. Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/MTOR signaling pathway in nasopharyngeal cancer cells. Int. J. Mol. Med. 2015;36:1556\u20131562. doi: 10.3892/ijmm.2015.2378.", "ArticleIdList": ["10.3892/ijmm.2015.2378", "PMC4678157", "26499488"]}, {"Citation": "Tamura M., Matsui H., Tomita T., Sadakata H., Indo H.P., Majima H.J., Kaneko T., Hyodo I. Mitochondrial reactive oxygen species accelerate gastric cancer cell invasion. J. Clin. Biochem. Nutr. 2013:12\u201317. doi: 10.3164/jcbn.13-36.", "ArticleIdList": ["10.3164/jcbn.13-36", "PMC3882482", "24426185"]}, {"Citation": "Wang W.-J., Kuo J.-C., Yao C.-C., Chen R.-H. DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J. Cell Biol. 2002;159:169\u2013179. doi: 10.1083/jcb.200204050.", "ArticleIdList": ["10.1083/jcb.200204050", "PMC2173490", "12370243"]}, {"Citation": "Jang C.-W., Chen C.-H., Chen C.-C., Chen J., Su Y.-H., Chen R.-H. TGF-\u03b2 induces apoptosis through smad-mediated expression of DAP-kinase. Nat. Cell Biol. 2002;4:51\u201358. doi: 10.1038/ncb731.", "ArticleIdList": ["10.1038/ncb731", "11740493"]}, {"Citation": "Dawson C.W., Port R.J., Young L.S. Seminars in Cancer Biology. Volume 22. Elsevier; Amsterdam, The Netherlands: 2012. The Role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the Pathogenesis of Nasopharyngeal Carcinoma (NPC) pp. 144\u2013153.", "ArticleIdList": ["22249143"]}, {"Citation": "Lo K.-W., Chung G.T.-Y., To K.-F. Seminars in Cancer Biology. Volume 22. Elsevier; Amsterdam, The Netherlands: 2012. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches; pp. 79\u201386.", "ArticleIdList": ["22245473"]}, {"Citation": "Xiao L., Hu Z.Y., Dong X., Tan Z., Li W., Tang M., Chen L., Yang L., Tao Y., Jiang Y. Targeting epstein\u2013barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy. Oncogene. 2014;33:4568\u20134578. doi: 10.1038/onc.2014.32.", "ArticleIdList": ["10.1038/onc.2014.32", "PMC4162460", "24662831"]}, {"Citation": "Roskoski R., Jr. ERK1/2 MAP kinases: Structure, function, and regulation. Pharmacol. Res. 2012;66:105\u2013143. doi: 10.1016/j.phrs.2012.04.005.", "ArticleIdList": ["10.1016/j.phrs.2012.04.005", "22569528"]}, {"Citation": "McCormick F. KRAS as a therapeutic target. Clin. Cancer Res. 2015;21:1797\u20131801. doi: 10.1158/1078-0432.CCR-14-2662.", "ArticleIdList": ["10.1158/1078-0432.CCR-14-2662", "PMC4407814", "25878360"]}, {"Citation": "Bates S.E. Targeting RAS: The elusive prize. Clin. Cancer Res. 2015;21:1796. doi: 10.1158/1078-0432.CCR-14-2664.", "ArticleIdList": ["10.1158/1078-0432.CCR-14-2664", "25878359"]}, {"Citation": "Weiming X.U., Liu L.Z., Loizidou M., Ahmed M., Charles I.G. The Role of Nitric Oxide in Cancer. Cell Res. 2002;12:311\u2013320.", "ArticleIdList": ["12528889"]}, {"Citation": "Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis. 1998;19:711\u2013721. doi: 10.1093/carcin/19.5.711.", "ArticleIdList": ["10.1093/carcin/19.5.711", "9635855"]}, {"Citation": "Wink D.A., Ridnour L.A., Hussain S.P., Harris C.C. The reemergence of nitric oxide and cancer. Nitric Oxide Biol. Chem. J. Nitric Oxide Soc. 2008;19:65. doi: 10.1016/j.niox.2008.05.003.", "ArticleIdList": ["10.1016/j.niox.2008.05.003", "PMC2565861", "18638716"]}, {"Citation": "Choudhari S.K., Chaudhary M., Bagde S., Gadbail A.R., Joshi V. Nitric oxide and cancer: A review. World J. Surg. Oncol. 2013;11:1\u201311. doi: 10.1186/1477-7819-11-118.", "ArticleIdList": ["10.1186/1477-7819-11-118", "PMC3669621", "23718886"]}, {"Citation": "Hirata Y., Nakanishi K. Grifolin, an antibiotic from a basidiomycete. J. Biol. Chem. 1950;184:135\u2013143. doi: 10.1016/S0021-9258(19)51132-2.", "ArticleIdList": ["10.1016/S0021-9258(19)51132-2", "15421982"]}, {"Citation": "Isobe M., Goto T. Synthesis of grifolin, an antibiotic from a basidiomycete. Tetrahedron. 1968;24:945\u2013948. doi: 10.1016/0040-4020(68)88044-5.", "ArticleIdList": ["10.1016/0040-4020(68)88044-5", "5637493"]}, {"Citation": "Sugiyama K., Tanaka A., Kawagishi H., Ojima F., Sakamoto H., Ishiguro Y. Hypocholesterolemic action of dietary grifolin on rats fed with a high-cholesterol diet. Biosci. Biotechnol. Biochem. 1994;58:211\u2013212. doi: 10.1271/bbb.58.211.", "ArticleIdList": ["10.1271/bbb.58.211", "27315726"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "30"}, {"Year": "2021", "Month": "12", "Day": "31"}, {"Year": "2021", "Month": "12", "Day": "31"}, {"Year": "2022", "Month": "1", "Day": "11", "Hour": "1", "Minute": "14"}, {"Year": "2022", "Month": "1", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["35011516", "PMC8746472", "10.3390/molecules27010284", "molecules27010284"]}}], "PubmedBookArticle": []}